🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to assess the efficacy (overall respon...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Start Date
2025-03-17
Trial ID
NCT06356571
The purpose of this study is to assess the evolution of disease control, he...
Status
Active Not Recruiting
Location
Centro de Salud de Jerez Sur
Start Date
2017-07-26
Trial ID
NCT04480242
Primary Objectives: * Phase 1: To characterize the safety and tolerability...
Status
Terminated
Location
Investigational Site Number :8400003
Start Date
2020-06-18
Trial ID
NCT04294459
The purpose of this study is to determine whether patients with asthma who ...
Status
Completed
Location
Maternal and Child Health Sciences, Ninewells Hospital and Medical School
Start Date
2007-08
Trial ID
NCT00655616
Treatments Being Tested
Primary Objectives: * Safety run-in Part: To confirm the recommended dose ...
Status
Active Not Recruiting
Location
UCLA Site Number : 8400010
Start Date
2020-06-16
Trial ID
NCT04270409
Background: \- Chronic Graft Versus Host Disease (cGVHD) can occur after a...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2021-05-10
Trial ID
NCT04294641
This is a randomized, multicenter, Phase 3, open-label study evaluating sub...
Status
Active Not Recruiting
Location
Mohtaseb Cancer Center and Blood Disorders Site Number : 8400028
Start Date
2022-06-23
Trial ID
NCT05405166
The purpose of this study is to evaluate the safety, tolerability, and dose...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-18
Trial ID
NCT01998971
This is a single-arm study of daratumumab in metastatic non-small cell lung...
Status
Completed
Location
NYU Langone Health
Start Date
2023-06-01
Trial ID
NCT05807048
Treatments Being Tested